Supernus Pharmaceuticals, Inc.SUPNNASDAQ
LOADING
|||
Alerts
Want to monitor SUPN?
Get notified when price crosses targets, volume spikes, or RSI hits oversold
Create free account to monitor SUPNWant to monitor SUPN?
Get notified when price crosses targets, volume spikes, or RSI hits oversold
Create free account to monitor SUPNpioneering new medicines in neurology and psychiatry with more than 20 years of experience, we are a specialty pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (cns) disorders. in 2013 we launched oxtellar xr® and trokendi xr®, two novel neurology products for the treatment of epilepsy. we are also developing several product candidates in psychiatry to address unmet medical needs and opportunities in attention-deficit hyperactivity disorder (adhd) and its coexisting disorders, and depression.